DRUG · COUNSELLING NOTES
Brexucabtagene Autoleucel
TECARTUS
Updated
New prescription
indication: _____. single IV infusion given in hospital; no driving 8 weeks; warned on allergies; AEs: cytokine release syndrome, neurotoxicity, fever; non-pharm: infection precautions.
Refill prescription
refilled, adherence discussed, no SEs were reported
Dose change
Dose change discussed. new dose reviewed; single IV infusion given in hospital; no driving 8 weeks; warned on allergies; AEs: cytokine release syndrome, neurotoxicity, fever; non-pharm: infection precautions.